Montreal, June 25, 2025 – The DNA to RNA Initiative (D2R) at McGill University has awarded $400,000 to four projects that aim to bring RNA-based innovations closer to clinical and commercial reality, including vaccines and therapies for rare and infectious diseases.

Classified as: RNA, Major Partnerships, Commercialization Priming, Awards
Published on: 25 Jun 2025

McGill University, the Institut de recherches cliniques de Montréal (IRCM) and Université de Sherbrooke, partners in the RNA Network for Therapy Development & Production (Réseau DePTAQ), are pleased to announce the appointment of Panagiotis (Takis) Prinos, PhD, as Director of Réseau DePTAQ.

Classified as: DePTAQ, RNA
Published on: 11 Apr 2025

D2R is pleased to launch the call for proposals for the Foundational and Research in Motion funding program.

This program integrates two previously separate funding programs - Foundational Projects and Research in Motion (RIM) - into a single, unified call. This program provides researchers with the flexibility to explore novel ideas and develop cutting-edge solutions that have the potential to lead to commercialization or clinical application.

Classified as: RNA, Genomic medicine, call for proposals, Research
Published on: 3 Apr 2025

Montreal, March 26, 2025 – McGill University’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Classified as: RNA, Research and Innovation, Awards, Cancer
Published on: 26 Mar 2025

The D2R (DNA to RNA) Initiative has awarded more than $6 million to support eight Core Platforms at McGill University and one at the University of British Columbia through its Core Platform Sustainability funding program. This program supports state-of-the-art Core Platforms that are essential for advancing research and development and facilitating technology uptake and transfer in fields relevant to RNA therapeutics.

Classified as: Core Platforms, RNA, RNA therapeutics, Research and Innovation
Published on: 7 Feb 2025

As part of the Distinguished Professors Lecture Series by RI-MUHC, Professor Sir Paul Nurse, Chief Executive Officer of The Francis Crick Institute and Nobel Laureate in Physiology or Medicine will be giving two lectures on May 1 and May 2, 2024. Details in the posters above. 

RSVP as soon as possible to manon.desrosiers [at] muhc.mcgill.ca as the places are limited.

 

Classified as: RNA
Category:
Published on: 23 Apr 2024
Back to top